1
Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
Condition(s):HypertensionLast Updated:April 26, 2011Completed
Amlodipine and Valsartan: 85 Clinical Trials
Hide Studies Not Open or Pending
2
Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects
Condition(s):HealthyLast Updated:September 11, 2017Completed
3
Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet
Condition(s):HealthyLast Updated:September 11, 2013Completed
4
Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers
Condition(s):HealthyLast Updated:April 9, 2013Completed
5
Study of Efficacy and Safety of CVAA489 in Hypertensive Patients
Condition(s):Essential HypertensionLast Updated:February 7, 2017Completed
6
Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
Condition(s):HypertensionLast Updated:March 24, 2017Completed
7
Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial
Condition(s):Essential HypertensionLast Updated:November 6, 2018Completed
8
Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level
Condition(s):HypertensionLast Updated:June 18, 2019Completed
9
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
Condition(s):Stage 2 Systolic HypertensionLast Updated:March 1, 2011Completed
10
To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
Condition(s):Hypertension; High Blood PressureLast Updated:September 13, 2011Completed
11
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
Condition(s):HypertensionLast Updated:April 26, 2011Completed
12
PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension
Condition(s):Essential HypertensionLast Updated:November 11, 2015Completed
13
A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy
Condition(s):Primary HypertensionLast Updated:February 21, 2017Completed
14
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
Condition(s):HypertensionLast Updated:June 8, 2011Completed
15
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
Condition(s):HypertensionLast Updated:June 7, 2011Completed
16
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
Condition(s):Essential HypertensionLast Updated:May 18, 2011Completed
17
A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland)
Condition(s):HealthyLast Updated:September 8, 2019Active, not recruiting
18
Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients
Condition(s):HypertensionLast Updated:May 31, 2012Completed
19
The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction
Condition(s):Hypertension; Diastolic DysfunctionLast Updated:April 19, 2012Completed
20
Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
Condition(s):HypertensionLast Updated:May 16, 2017Completed
21
Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension
Condition(s):HypertensionLast Updated:January 8, 2019Active, not recruiting
22
A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)
Condition(s):HealthyLast Updated:August 5, 2015Completed
23
Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
Condition(s):Hypertension; Hypertrophy, Left VentricularLast Updated:May 6, 2011Completed
24
The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy
Condition(s):HypertensionLast Updated:September 20, 2016Completed
25
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.
Condition(s):HypertensionLast Updated:November 22, 2011Completed
26
Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
Condition(s):Essential HypertensionLast Updated:November 3, 2014Completed
27
Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients
Condition(s):Lower Leg Edema; Orthostatic HypertensionLast Updated:April 18, 2016Unknown status
28
Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
Condition(s):HypertensionLast Updated:June 17, 2008Completed
29
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
Condition(s):HypertensionLast Updated:November 7, 2011Completed
30
Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day
Condition(s):HypertensionLast Updated:May 16, 2011Completed
31
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
Condition(s):HypertensionLast Updated:June 2, 2011Completed
32
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Condition(s):HypertensionLast Updated:May 4, 2011Completed
33
Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
Condition(s):HypertensionLast Updated:August 20, 2008Completed
34
A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
Condition(s):HypertensionLast Updated:November 16, 2016Completed
35
Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
Condition(s):Essential HypertensionLast Updated:April 20, 2011Completed
36
Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
Condition(s):HypertensionLast Updated:November 15, 2016Completed
37
Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg
Condition(s):HealthyLast Updated:April 29, 2012Completed
38
Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
Condition(s):HypertensionLast Updated:September 24, 2010Completed
39
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
Condition(s):HypertensionLast Updated:May 15, 2017Completed
40
Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg
Condition(s):HypertensionLast Updated:March 8, 2011Completed
41
One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
Condition(s):HypertensionLast Updated:November 7, 2011Completed
42
A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
Condition(s):HYPERTENSIONLast Updated:November 7, 2011Completed
43
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone
Condition(s):HypertensionLast Updated:May 15, 2017Completed
44
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
Condition(s):HypertensionLast Updated:November 16, 2016Completed
45
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
Condition(s):HypertensionLast Updated:November 16, 2016Completed
46
A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy
Condition(s):HypertensionLast Updated:November 16, 2016Completed
47
Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
Condition(s):HypertensionLast Updated:November 7, 2011Completed
48
8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
Condition(s):HypertensionLast Updated:November 7, 2011Completed
49
Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients
Condition(s):Essential HypertensionLast Updated:July 16, 2008Unknown status
50
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
Condition(s):HypertensionLast Updated:November 7, 2011Completed
51
Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome
Condition(s):HypertensionLast Updated:June 9, 2015Completed
52
Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance
Condition(s):Hypertension; Type 2 Diabetes MellitusLast Updated:April 29, 2013Completed
53
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
Condition(s):Hypertension; HyperlipidemiaLast Updated:August 19, 2018Enrolling by invitation
54
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
Condition(s):HypertensionLast Updated:November 7, 2011Completed
55
Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
Condition(s):HypertensionLast Updated:February 22, 2017Completed
56
Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients
Condition(s):Hypertension; ObesityLast Updated:August 2, 2018Not yet recruiting
57
Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia
Condition(s):Hypertension With HyperlipidemiaLast Updated:May 28, 2018Completed
58
Rationale and Design for Shiga Microalbuminuria Reduction Trial
Condition(s):Hypertension; Diabetes Mellitus; AlbuminuriaLast Updated:April 27, 2006Unknown status
59
Diva – The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
Condition(s):Hypertension; Metabolic SyndromeLast Updated:November 7, 2011Completed
60
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)
Condition(s):Healthy Male SubjectsLast Updated:August 24, 2018Completed
61
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
Condition(s):HypertensionLast Updated:November 16, 2016Completed
62
Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
Condition(s):HypertensionLast Updated:April 19, 2017Completed
63
Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects
Condition(s):HealthyLast Updated:December 28, 2016Completed
64
ADDM Study – Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
Condition(s):Hypertension; Diabetes Mellitus, Type 2; AlbuminuriaLast Updated:June 16, 2011Completed
65
Intermittent Hypoxia 2: Cardiovascular and Metabolism
Condition(s):Hypoxia; Sleep Apnea; Obstructive Sleep ApneaLast Updated:December 27, 2018Terminated
66
The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
Condition(s):Diabetes; Hypertension; ProteinuriaLast Updated:June 16, 2009Completed
67
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)
Condition(s):Healthy Male SubjectsLast Updated:August 1, 2018Completed
68
Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
Condition(s):Hypertension; Chronic Kidney DiseaseLast Updated:June 13, 2016Completed
69
Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers
Condition(s):Hypertension; HyperlipidemiasLast Updated:January 3, 2017Completed
70
Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
Condition(s):HypertensionLast Updated:January 24, 2012Completed
71
Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial
Condition(s):Blood PressureLast Updated:November 14, 2013Completed
72
Bioequivalence Study of CJ-30061 in Healthy Male Volunteers
Condition(s):Hypertension; HyperlipidemiaLast Updated:September 2, 2018Completed
73
The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy
Condition(s):HypertensionLast Updated:April 11, 2017Completed
74
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
Condition(s):Insulin Sensitivity; Aortic Compliance; Diastolic FunctionLast Updated:January 18, 2018Terminated
75
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
Condition(s):HypertensionLast Updated:November 30, 2012Completed
76
Bioequivalence Study of CJ-30060 in Healthy Volunteers
Condition(s):Healthy SubjectsLast Updated:November 25, 2018Recruiting
77
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects
Condition(s):Healthy Male SubjectsLast Updated:March 25, 2013Completed
78
Bioequivalence Study of CJ-30060 in Healthy Male Volunteers
Condition(s):Healthy Male SubjectsLast Updated:August 19, 2018Completed
79
The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
Condition(s):PreDiabetes; Impaired Glucose Tolerance; Obesity; Blood PressureLast Updated:May 3, 2019Not yet recruiting
80
Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
Condition(s):HypertensionLast Updated:March 31, 2016Completed
81
The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome
Condition(s):Hypertension; Metabolic SyndromeLast Updated:November 14, 2013Withdrawn
82
Regression of Fatty Heart by Valsartan Therapy
Condition(s):Metabolic Syndrome; LipotoxicityLast Updated:January 16, 2019Withdrawn
83
Role of ARNi in Ventricular Remodeling in Hypertensive LVH
Condition(s):Hypertensive Heart DiseaseLast Updated:May 30, 2018Not yet recruiting
84
A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension
Condition(s):HypertensionLast Updated:March 29, 2019Completed
85
Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
Condition(s):Hypertension; Left Ventricular HypertrophyLast Updated:August 15, 2012Completed